Anesthetics and Cerebral Oxygenation in LSG

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 20, 2019

Primary Completion Date

June 1, 2019

Study Completion Date

June 1, 2019

Conditions
Morbid ObesityBariatric Surgery CandidateAnesthesia
Interventions
DRUG

Inhalational anesthetic

Oxygen/air (fraction of inspired oxygen (FiO2) of 0.40), inspiratory fresh gas flow of 2 L/min), sevoflurane (1 minimum alveolar concentration \[MAC\]) and remifentanil IV infusion (0.1-0.25 mcg/kg of LBW/min) were used.Neuromuscular blockade was performed during the operation by rocuronium infusion (0.3-0.7 mg/kg of LBW/h), ensuring that PTC was zero.

DRUG

Intravenous anesthetic

Propofol infusion (4-8 mg/kg of total body weight/h), oxygen/air (FiO2 of 0.40; inspiratory fresh gas flow of 2 L/min) and remifentanil IV infusion (0.1-0.25 μg/kg of LBW/min) were used.Neuromuscular blockade was performed during the operation by rocuronium infusion (0.3-0.7 mg/kg of LBW/h), ensuring that PTC was zero.

Trial Locations (1)

55139

Ondokuz Mayis Universitesi, Samsun

All Listed Sponsors
lead

Ondokuz Mayıs University

OTHER

NCT03946657 - Anesthetics and Cerebral Oxygenation in LSG | Biotech Hunter | Biotech Hunter